Immunological monitoring of the tumor immunoenvironment for clinical trials.

Immunological monitoring of the tumor immunoenvironment for clinical trials.

Item
http://www.wikidata.org/entity/Q37955680
Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.HSP70 promoter-driven activation of gene expression for immunotherapy using gold nanorods and near infrared light.The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer.Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells.ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor.Clinical evaluation of systemic and local immune responses in cancer: time for integration.Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy.Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC.Modern strategies and capabilities for activation of the immune response against tumor cells.Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.Chemotherapy ± cetuximab modulates peripheral immune responses in metastatic colorectal cancer.
P2860

Immunological monitoring of the tumor immunoenvironment for clinical trials.

Item
http://www.wikidata.org/entity/Q37955680
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Immunological monitoring of the tumor immunoenvironment for clinical trials.
@en
Immunological monitoring of the tumor immunoenvironment for clinical trials.
@nl
type
label
Immunological monitoring of the tumor immunoenvironment for clinical trials.
@en
Immunological monitoring of the tumor immunoenvironment for clinical trials.
@nl
prefLabel
Immunological monitoring of the tumor immunoenvironment for clinical trials.
@en
Immunological monitoring of the tumor immunoenvironment for clinical trials.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Immunological monitoring of the tumor immunoenvironment for clinical trials.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921